IP Library Granted Patent US 10,052,351
Granted Patent B2
US 10,052,351 · App. 14/601,075 · Granted Aug 21, 2018

Method for inducing angiogenesis

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,052,351
App. No.
14/601,075
Filed
Jan 20, 2015
Granted
Aug 21, 2018
Kind
B2
Art Unit
1651
USPC
424/93.7
Abstract

Disclosed herewith is a method for inducing angiogenesis using modified placental tissue or an extract thereof to treat conditions other than cardiovascular conditions.

Claims (15)

1. A method for inducing angiogenesis in a non-cardiovascular body region of a subject comprising delivering an effective amount of a composition comprising modified placental tissue to said non-cardiovascular body region, wherein said modified placental tissue comprises an amnion layer having an exposed basement layer; wherein the composition is administered by a nebulizer.

2. The method of claim 1 , wherein blood flow to the non-cardiovascular body region is restricted.

3. The method of claim 2 , wherein the blood flow to the non-cardiovascular body region is restricted due to damage or disease.

4. The method of claim 1 , wherein the non-cardiovascular body region includes liver, lung, nerve, bone, skin, or peripheral portions of the body.

5. The method of claim 4 , wherein the peripheral portions of the body are limbs, hands, or feet.

6. The method of claim 1 , wherein the subject has peripheral neuropathy, cirrhosis, a pulmonary condition, bone necrosis, ischemia, organ injury, tissue injury, or a chronic wound.

7. The method of claim 6 , wherein the pulmonary condition is selected from the group consisting of cystic fibrosis, pulmonary fibrosis, and chronic obstructive pulmonary disease (COPD).

8. The method of claim 6 , wherein the ischemia is limb ischemia.

9. The method of claim 6 , wherein the chronic wound is associated with systemic disease.

10. The method of claim 1 , wherein the modified placental tissue further comprises one or more of isolated amnion, isolated chorion, intermediate layer, Wharton's jelly, isolated amniotic epithelial layer, or any combination thereof.

11. The method of claim 1 , wherein the modified placental tissue is a tissue graft.

12. The method of claim 1 , wherein the modified placental tissue is micronized.

13. The method of claim 1 , wherein the composition is a liquid.

14. A method for inducing angiogenesis in a non-cardiovascular body region of a subject wherein blood to said region is restricted due to injury or disease which method comprises delivering an effective amount of an aqueous solution comprising micronized modified placental tissue particles to said subject and maintaining said region under conditions wherein angiogenesis is induced; wherein said particles comprise an amnion layer having an exposed basement layer; and wherein the solution is administered by a nebulizer.

15. The method of claim 14 , wherein the non-cardiovascular body region includes liver, lung, nerve, bone, skin, or peripheral portions of the body.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2024
From: HAYFIN SERVICES LLP
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 066493/0322 →
SECURITY INTEREST Recorded Jan 25, 2024
From: MIMEDX GROUP, INC.
To: CITIZENS BANK, N.A.
Reel/Frame 066371/0136 →
PATENT SECURITY AGREEMENT Recorded Jul 2, 2020
From: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
To: HAYFIN SERVICES LLP, AS COLLATERAL AGENT
Reel/Frame 053121/0833 →
RELEASE OF SECURITY INTEREST Recorded Jul 2, 2020
From: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
To: MIMEDX GROUP, INC.; MIMEDX PROCESSING SERVICES, LLC
Reel/Frame 054075/0687 →
SECURITY INTEREST Recorded Jun 11, 2019
From: MIMEDX GROUP, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 049426/0863 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS Recorded Jan 24, 2019
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: MIMEDX GROUP, INC.
Reel/Frame 048121/0835 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Oct 15, 2015
From: MIMEDX GROUP, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 036872/0498 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2015
From: KOOB, THOMAS J.
To: MIMEDX GROUP, INC.
Reel/Frame 036569/0837 →
Cited By (2)
US 12,247,225 US 12,551,509